Ashwini Deshpande

GM - India & South Asia

The animal health market in India is experiencing con­tinuous growth, driven by the increasing number of pet owners and the rising emphasis on preventing and treating diseases in companion animals. According to Vantage Market Research, the Global Animal Healthcare Market was valued at $141.2 Billion in 2021 and is project­ed to reach $181.7 Billion by 2028. Furthermore, while the Indian animal health market was valued at Rs.73.4 Billion in 2022, it is expected to grow exhibiting a CAGR of 8.94 per­cent during 2023-2028 (according to IMARC Impactful In­sights). These statistics not only demonstrate the promising trajectory of the animal health market in India but also man­ifest the significant opportunities for companies like Zoetis India, to make a substantial impact in this thriving industry.

The Prime Player

Zoetis, as the world's leading animal health company, is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. With over 70 years of experience in innovating ways to predict, prevent, detect, and treat animal illnesses, Zoetis remains dedicated to supporting those who raise and care for animals worldwide ranging from veterinarians and pet parents to livestock farmers and ranchers. As a Fortune 500 company, the company generated revenue of $8.1 billion in 2022 and employs approximately 13,800 people.

Establishing its presence in India in 2013, Zoetis has been a trusted partner for Indian customers and stakeholders, working towards improving the health and welfare of animals, people, and communities not only in India but also in other territories Bangladesh, Nepal, and Sri Lanka.

Comprehensive Solutions & Support

Recognizing the diverse needs of customers in the animal health segment, Zoetis India provides an extensive portfolio that caters to both the companion animal and livestock sectors. Its range of flagship products in the companion animal market is truly exceptional. From a powerful antibiotic used for treating a wide range of bacterial infections in cats and dogs, to a breakthrough topical treatment for fleas, ticks, and heartworms, Zoetis India ensures the health and happiness of beloved pets. Furthermore, vaccines offer robust protection against common feline and canine diseases, respectively.

Zoetis India is at the forefront of diagnostic advancements, empowering veterinarians with diagnostics. These cutting-edge devices provide rapid and accurate test results within minutes, revolutionizing the way veterinarians diagnose and treat animals. Whether it's detecting infectious diseases, assessing organ function, or monitoring overall health, Zoetis India's diagnostic solutions streamline the diagnostic process, enabling timely interventions and precise treatment plans.

The company’s impact extends beyond companion animals to the poultry industry, where their revolutionary solutions have transformed the landscape of poultry health. The Embrex biodevice represents a paradigm shift in vaccine administration technology. By introducing In- Ovo Vaccination through Embrex biodevices and In-Ovo recommended vaccines, Zoetis India has revolutionized the way Innovative poultry vaccines are administered. With this groundbreaking approach, disease protection is initiated in chicks before hatch¹, resulting in enhanced immunization, improved bird health and performance, and increased hatchery efficiency. Zoetis India's commitment to continuous improvement ensures that its Innovative Hatchery vaccines, Layer Vaccines and Breeder Vaccines, consistently evolve to meet the ever-changing needs of the poultry industry.

Operating in over 100 countries, Zoetis continues to make a significant global impact on animal health. Its portfolio of proven, safe, and efficacious products is supported by a team of dedicated experts, ensuring that customers receive the best possible solutions. Zoetis India's collaborations with poultry producers worldwide exemplify its commitment to fostering a sustainable and efficient industry. By helping poultry producers raise healthy birds more effectively, the company plays a vital role in fulfilling the industry's commitment to providing safe, nutritious, and affordable protein to a growing population.

Innovation & Global Success

Zoetis stays ahead of the curve by adopting innovative methodologies to advance animal care. They prioritize innovation, customer obsession, and purpose-driven colleagues. Backed by high science and technology, the brand’s products contribute to the advancement of veterinary practices and livestock farming. Leveraging digital solutions and data insights, Zoetis powers its business, supports its workforce, promotes sustainability, and strives for excellence and agility.

One of Zoetis' notable contributions in India is revolutionizing poultry vaccination through In-Ovo Vaccination. Its Embrex biodevices and Innovative In-Ovo recommended vaccines enable integrators & hatchery owners to achieve better vaccination control, giving chicks a three-day head start to build an immune response compared to traditional vaccines, with improved chicks’ quality and improved farm performance. Their innovative devices, proven vaccines, and specialized knowledge have created value for their customers and contributed to healthier chickens, and specialized knowledge have created value for their customers and contributed to healthier chickens.

With a focus on providing India and South Asia with access to their innovative global portfolio, Zoetis emphasizes enhancing their digital capabilities, continuous learning, and raising awareness about topics in animal healthcare.

They envision long-term sustainable growth driven by new products and lifecycle innovations, shaping and expanding the future of animal care. It aims to forge ahead with game-changing franchises through internal research and development efforts and strategic business collaborations.

Zoetis India takes great pride in the exceptional contributions of its colleagues, who have played a crucial role in the company's success. They remain committed to prioritizing the personal and professional growth of their employees, fostering a collaborative culture that promotes inclusion and ensures their well-being.

References :

1. Barbosa T, Williams C, Villalobos T. Efficacy and Marek’s disease protection comparison between different vaccination methods, in Proceedings. 18th Congress World Veterinary Poultry Association 2013;217.

2. Williams CJ. Effects of Automated Clear Egg Removal Prior To Transfer and Vaccination. July 2002.

3. Vieira SL, Moran Jr. ET. Effects of egg of origin and chick post-hatch nutrition on broiler live performance and meat yields. Worlds Poult Sci J.1999;55(2):125-142.

4. Halevy O, Geyra A, Barak M, Uni Z, Sklan D. Early Posthatch Starvation Decreases Satellite Cell Proliferation and Skeletal Muscle Growth in Chicks. J Nutr. 2000;130(4):858-864.